Medpace Holdings Inc (MEDP) support and resistance · P/E 25, rev $707.3M
Medpace Holdings Inc (MEDP) is a diagnostics & research company listed on US.
This page maps Medpace Holdings Inc (MEDP) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported MEDP revenue for 2026-06-30 was $707.3M. Net income was $121.4M. Revenue was up 0.1% from 2026-03-31 to 2026-06-30. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
MEDP currently screens at market cap $9.30B and trailing P/E 24.7. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new MEDP 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the MEDP quote page for the session range and the stock page for the full model.
Not investment advice.